ANI PHARMACEUTICALS, INC (ANIP) Gross margin 2016–2020
ANI PHARMACEUTICALS, INC (ANIP) gross margin by fiscal year — reported gross profit divided by reported revenue.
58.2%FY2020 · since FY2016: 62.1% → 58.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | 58.2% | -11.2 pp |
| FY2019 | 69.4% | +5.7 pp |
| FY2018 | 63.8% | +8.5 pp |
| FY2017 | 55.3% | -6.8 pp |
| FY2016 | 62.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANIP financial trends
ANIP RevenueANIP Net incomeANIP Net marginANIP Gross profitANIP Operating incomeANIP Operating marginANIP Operating cash flowANIP Free cash flowANIP Capital expendituresANIP Return on equityANIP Stock buybacksANIP Dividends paidANIP Total assetsANIP Total liabilitiesANIP Shareholders’ equityANIP overview →